Princeton Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,820
Closed -$217K 95
2020
Q2
$217K Hold
2,820
0.1% 86
2020
Q1
$218K Buy
+2,820
New +$195K 0.11% 79
2019
Q4
Sell
-2,976
Closed -$189K 134
2019
Q3
$189K Hold
2,976
0.09% 90
2019
Q2
$201K Sell
2,976
-140
-4% -$9.21K 0.1% 88
2019
Q1
$203K Sell
3,116
-40
-1% -$2.66K 0.1% 93
2018
Q4
$197K Sell
3,156
-1,865
-37% -$130K 0.11% 90
2018
Q3
$388K Hold
5,021
0.16% 71
2018
Q2
$356K Sell
5,021
-281
-5% -$19.8K 0.15% 71
2018
Q1
$400K Hold
5,302
0.18% 68
2017
Q4
$380K Buy
+5,302
New +$403K 0.17% 70
2016
Q4
$1.24M Sell
17,340
-3,130
-15% -$233K 1.8% 13
2016
Q3
$1.62M Sell
20,470
-1,248
-6% -$101K 2% 10
2016
Q2
$1.81M Buy
21,718
+1,619
+8% +$144K 2.07% 5
2016
Q1
$1.85M Buy
20,099
+494
+3% +$44.5K 2.08% 5
2015
Q4
$1.98M Buy
19,605
+81
+0.4% +$8.43K 2.23% 6
2015
Q3
$1.92M Sell
19,524
-912
-4% -$101K 2.18% 4
2015
Q2
$2.39M Sell
20,436
-1,105
-5% -$121K 2.42% 2
2015
Q1
$2.11M Buy
21,541
+215
+1% +$21.8K 2.06% 3
2014
Q4
$2.01M Sell
21,326
-1,777
-8% -$184K 1.99% 5
2014
Q3
$2.46M Sell
23,103
-4,092
-15% -$401K 2.24% 4
2014
Q2
$2.25M Buy
27,195
+4
+0% +$311 1.9% 8
2014
Q1
$1.93M Sell
27,191
-900
-3% -$70.6K 1.62% 12
2013
Q4
$2.11M Sell
28,091
-1,359
-5% -$94.6K 1.75% 8
2013
Q3
$1.85M Sell
29,450
-2,452
-8% -$147K 1.69% 9
2013
Q2
$1.64M Buy
+31,902
New +$1.66M 1.55% 12

Other funds holding GILD

Princeton Capital Management's GILD Position: Q3 2020 in Review

Princeton Capital Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,820 shares — an estimated $217K sold.

Princeton Capital Management first reported a position in GILD in Q2 2013 and held it in 25 quarters. The position peaked at $2.46M in Q3 2014. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Princeton Capital Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Princeton Capital Management sold 2,820 Gilead Sciences shares in Q3 2020, an estimated $217K.
  • Princeton Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 25 quarters.
  • Princeton Capital Management's Gilead Sciences position peaked at $2.46M in Q3 2014.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Princeton Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.